Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 6.84764093 |
2 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 5.87173477 |
3 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.03437606 |
4 | DNA deamination (GO:0045006) | 3.92412061 |
5 | folic acid metabolic process (GO:0046655) | 3.89898307 |
6 | protein localization to kinetochore (GO:0034501) | 3.88747350 |
7 | necroptotic process (GO:0070266) | 3.71998958 |
8 | protein localization to chromosome, centromeric region (GO:0071459) | 3.65064425 |
9 | negative regulation of cell killing (GO:0031342) | 3.59958868 |
10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59958868 |
11 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55119608 |
12 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.44320153 |
13 | nucleobase biosynthetic process (GO:0046112) | 3.40473737 |
14 | tolerance induction (GO:0002507) | 3.39652164 |
15 | positive regulation of interleukin-17 production (GO:0032740) | 3.37471988 |
16 | T-helper 1 type immune response (GO:0042088) | 3.31059559 |
17 | mitotic nuclear envelope disassembly (GO:0007077) | 3.29065472 |
18 | neutrophil activation involved in immune response (GO:0002283) | 3.28531267 |
19 | mitotic metaphase plate congression (GO:0007080) | 3.23698445 |
20 | programmed necrotic cell death (GO:0097300) | 3.20433944 |
21 | sleep (GO:0030431) | 3.19164554 |
22 | purine nucleobase biosynthetic process (GO:0009113) | 3.16155799 |
23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.14370554 |
24 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.13011422 |
25 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.11732043 |
26 | formation of translation preinitiation complex (GO:0001731) | 3.09705178 |
27 | germinal center formation (GO:0002467) | 3.09681584 |
28 | cellular anion homeostasis (GO:0030002) | 3.09555811 |
29 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.07050993 |
30 | positive regulation of prostaglandin secretion (GO:0032308) | 3.06137005 |
31 | mitotic sister chromatid segregation (GO:0000070) | 3.05988880 |
32 | nuclear pore complex assembly (GO:0051292) | 3.05980502 |
33 | ribosome biogenesis (GO:0042254) | 3.05323409 |
34 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.04271502 |
35 | mitotic chromosome condensation (GO:0007076) | 3.03774907 |
36 | nuclear envelope disassembly (GO:0051081) | 3.02789582 |
37 | membrane disassembly (GO:0030397) | 3.02789582 |
38 | regulation of mast cell degranulation (GO:0043304) | 3.02726098 |
39 | leukocyte apoptotic process (GO:0071887) | 3.02041532 |
40 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.01732156 |
41 | regulation of hypersensitivity (GO:0002883) | 3.01211351 |
42 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.95800809 |
43 | nuclear pore organization (GO:0006999) | 2.95050923 |
44 | necrotic cell death (GO:0070265) | 2.93936081 |
45 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.93546748 |
46 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.93546748 |
47 | positive regulation by symbiont of host defense response (GO:0052509) | 2.89989561 |
48 | modulation by symbiont of host defense response (GO:0052031) | 2.89989561 |
49 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.89989561 |
50 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.89989561 |
51 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.89989561 |
52 | modulation by symbiont of host immune response (GO:0052553) | 2.89989561 |
53 | DNA replication initiation (GO:0006270) | 2.87823338 |
54 | regulation of spindle organization (GO:0090224) | 2.87204658 |
55 | T cell apoptotic process (GO:0070231) | 2.83994934 |
56 | leukocyte aggregation (GO:0070486) | 2.83044450 |
57 | natural killer cell mediated immunity (GO:0002228) | 2.82589747 |
58 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.82589747 |
59 | negative regulation of type I interferon production (GO:0032480) | 2.81150110 |
60 | DNA replication checkpoint (GO:0000076) | 2.80899467 |
61 | negative regulation of histone methylation (GO:0031061) | 2.80336181 |
62 | maturation of SSU-rRNA (GO:0030490) | 2.80156417 |
63 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.80116798 |
64 | regulation of translational termination (GO:0006449) | 2.80097837 |
65 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.79298087 |
66 | pyrimidine nucleoside salvage (GO:0043097) | 2.76290018 |
67 | pyrimidine-containing compound salvage (GO:0008655) | 2.76290018 |
68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75671037 |
69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75492518 |
70 | negative regulation of interleukin-12 production (GO:0032695) | 2.73971846 |
71 | regulation of protein heterodimerization activity (GO:0043497) | 2.72704070 |
72 | response to muramyl dipeptide (GO:0032495) | 2.72025391 |
73 | DNA unwinding involved in DNA replication (GO:0006268) | 2.71386822 |
74 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.69583716 |
75 | negative regulation of innate immune response (GO:0045824) | 2.69381337 |
76 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.69360699 |
77 | IMP biosynthetic process (GO:0006188) | 2.69326991 |
78 | regulation of leukocyte degranulation (GO:0043300) | 2.67323626 |
79 | mRNA stabilization (GO:0048255) | 2.67092477 |
80 | RNA stabilization (GO:0043489) | 2.67092477 |
81 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.66883734 |
82 | myeloid dendritic cell differentiation (GO:0043011) | 2.65794135 |
83 | sister chromatid segregation (GO:0000819) | 2.65554527 |
84 | negative regulation of interleukin-2 production (GO:0032703) | 2.65022171 |
85 | regulation of superoxide anion generation (GO:0032928) | 2.63127940 |
86 | cellular response to arsenic-containing substance (GO:0071243) | 2.61471351 |
87 | regulation of interleukin-17 production (GO:0032660) | 2.61041276 |
88 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.60272716 |
89 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.59957438 |
90 | macrophage activation involved in immune response (GO:0002281) | 2.58857909 |
91 | regulation of prostaglandin secretion (GO:0032306) | 2.57774552 |
92 | transcription from mitochondrial promoter (GO:0006390) | 2.56885722 |
93 | regulation of monocyte differentiation (GO:0045655) | 2.56743177 |
94 | ribosome assembly (GO:0042255) | 2.56734471 |
95 | regulation of mitotic spindle organization (GO:0060236) | 2.56500053 |
96 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.56266887 |
97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.55931657 |
98 | amino sugar catabolic process (GO:0046348) | 2.55882153 |
99 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.55664662 |
100 | intracellular pH reduction (GO:0051452) | 2.55402538 |
101 | regulation of chronic inflammatory response (GO:0002676) | 2.54904071 |
102 | pore complex assembly (GO:0046931) | 2.53500119 |
103 | positive regulation of B cell differentiation (GO:0045579) | 2.52071640 |
104 | folic acid-containing compound metabolic process (GO:0006760) | 2.51691017 |
105 | granulocyte activation (GO:0036230) | 2.51275487 |
106 | positive regulation of chromosome segregation (GO:0051984) | 2.51234795 |
107 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.50909473 |
108 | protein localization to chromosome (GO:0034502) | 2.50121182 |
109 | positive regulation of protein homooligomerization (GO:0032464) | 2.49368694 |
110 | regulation of translation in response to stress (GO:0043555) | 2.49311191 |
111 | metaphase plate congression (GO:0051310) | 2.49092262 |
112 | NIK/NF-kappaB signaling (GO:0038061) | 2.49003963 |
113 | heterochromatin organization (GO:0070828) | 2.48753757 |
114 | regulation of RNA export from nucleus (GO:0046831) | 2.48260013 |
115 | myeloid dendritic cell activation (GO:0001773) | 2.47885647 |
116 | modulation by symbiont of host cellular process (GO:0044068) | 2.47162612 |
117 | DNA strand elongation (GO:0022616) | 2.45887180 |
118 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.45788668 |
119 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.43836114 |
120 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.43684125 |
121 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.43471659 |
122 | response to protozoan (GO:0001562) | 2.42457312 |
123 | pinocytosis (GO:0006907) | 2.41877431 |
124 | negative regulation of T cell mediated immunity (GO:0002710) | 2.41850464 |
125 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.41049104 |
126 | regulation of gene silencing by miRNA (GO:0060964) | 2.41049104 |
127 | regulation of gene silencing by RNA (GO:0060966) | 2.41049104 |
128 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.40540067 |
129 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.40532855 |
130 | cell migration involved in heart development (GO:0060973) | 2.40242169 |
131 | regulation of histone H3-K9 methylation (GO:0051570) | 2.39853371 |
132 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.39797496 |
133 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.39504602 |
134 | glycosphingolipid catabolic process (GO:0046479) | 2.37781307 |
135 | nuclear envelope organization (GO:0006998) | 2.37166446 |
136 | B cell mediated immunity (GO:0019724) | 2.36756872 |
137 | rRNA modification (GO:0000154) | 2.36554451 |
138 | chromatin assembly or disassembly (GO:0006333) | 2.36174585 |
139 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.36115115 |
140 | regulation of chromatin binding (GO:0035561) | 2.35438184 |
141 | regulation of podosome assembly (GO:0071801) | 2.34946924 |
142 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.34815801 |
143 | pH reduction (GO:0045851) | 2.34773821 |
144 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.34736620 |
145 | IMP metabolic process (GO:0046040) | 2.34319237 |
146 | response to peptidoglycan (GO:0032494) | 2.34088022 |
147 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.33932790 |
148 | DNA duplex unwinding (GO:0032508) | 2.33834224 |
149 | regulation of gamma-delta T cell activation (GO:0046643) | 2.32831465 |
150 | DNA geometric change (GO:0032392) | 2.32777502 |
151 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.31673146 |
152 | defense response to protozoan (GO:0042832) | 2.31651373 |
153 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.31139782 |
154 | meiotic chromosome segregation (GO:0045132) | 2.30596004 |
155 | lymphocyte apoptotic process (GO:0070227) | 2.29472835 |
156 | tetrahydrofolate metabolic process (GO:0046653) | 2.29084074 |
157 | extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625) | 2.29029831 |
158 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.28679920 |
159 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.28481779 |
160 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.27623629 |
161 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.27430837 |
162 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.27429786 |
163 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.26718558 |
164 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.26512761 |
165 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.26495954 |
166 | immunoglobulin mediated immune response (GO:0016064) | 2.26021307 |
167 | regulation of integrin activation (GO:0033623) | 2.25615104 |
168 | establishment of chromosome localization (GO:0051303) | 2.25419931 |
169 | regulation of natural killer cell activation (GO:0032814) | 2.24732770 |
170 | positive regulation of interferon-beta production (GO:0032728) | 2.24645018 |
171 | rRNA processing (GO:0006364) | 2.24635075 |
172 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.23453663 |
173 | response to UV-C (GO:0010225) | 2.23363922 |
174 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.20948411 |
175 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.20948411 |
176 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.19349494 |
177 | rRNA metabolic process (GO:0016072) | 2.18722098 |
178 | modulation by virus of host process (GO:0019054) | 2.18377317 |
179 | glycine metabolic process (GO:0006544) | 2.18132801 |
180 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.17670899 |
181 | negative regulation of cell size (GO:0045792) | 2.16919900 |
182 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.16821821 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.74138380 |
2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.96839105 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.91108695 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.83774924 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.80510957 |
6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.68506680 |
7 | MYC_22102868_ChIP-Seq_BL_Human | 2.53346555 |
8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.45142414 |
9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.41419974 |
10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02380409 |
11 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.98566118 |
12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.97464074 |
13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.96205946 |
14 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.92628090 |
15 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.89636068 |
16 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87332023 |
17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84441304 |
18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83747981 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74879236 |
20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.72723526 |
21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.71950512 |
22 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71163941 |
23 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.70802756 |
24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69062069 |
25 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.67991290 |
26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.64848605 |
27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61690247 |
28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61356478 |
29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58037503 |
30 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.57451299 |
31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.51672542 |
32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51433820 |
33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.50748107 |
34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49936637 |
35 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.49267772 |
36 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.48080991 |
37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47471803 |
38 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.47265138 |
39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46959230 |
40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45646559 |
41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44698192 |
42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44633722 |
43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43724416 |
44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43500600 |
45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.43060226 |
46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42112549 |
47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40698279 |
48 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40174969 |
49 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38625257 |
50 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.37451828 |
51 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.37252153 |
52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.37144112 |
53 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35715223 |
54 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.35682009 |
55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35031191 |
56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34209383 |
57 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32944663 |
58 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32457173 |
59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32061377 |
60 | * MAF_26560356_Chip-Seq_TH1_Human | 1.31786245 |
61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31496515 |
62 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30445825 |
63 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30002135 |
64 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.27745932 |
65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25586072 |
66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25276810 |
67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25217107 |
68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24592822 |
69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24167700 |
70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23524255 |
71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23197308 |
72 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23097051 |
73 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22977071 |
74 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22727277 |
75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21914455 |
76 | * MYB_26560356_Chip-Seq_TH1_Human | 1.21425506 |
77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21381323 |
78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20820584 |
79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20730762 |
80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20084119 |
81 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20014954 |
82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19675193 |
83 | P68_20966046_ChIP-Seq_HELA_Human | 1.19353183 |
84 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.19303064 |
85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18641134 |
86 | MAF_26560356_Chip-Seq_TH2_Human | 1.18251827 |
87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17142951 |
88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16745901 |
89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16514483 |
90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16200538 |
91 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15932347 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15453395 |
93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15259662 |
94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15082495 |
95 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.15076203 |
96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14062503 |
97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13274035 |
98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12803807 |
99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12798915 |
100 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12604745 |
101 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12490720 |
102 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12174678 |
103 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.12166023 |
104 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11664536 |
105 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11396844 |
106 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10911998 |
107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10358132 |
108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10050976 |
109 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09037365 |
110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08534539 |
111 | MYB_26560356_Chip-Seq_TH2_Human | 1.04835874 |
112 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04715052 |
113 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03887944 |
114 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.01428891 |
115 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01260468 |
116 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01222471 |
117 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01101367 |
118 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01029863 |
119 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99603941 |
120 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99349768 |
121 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98676825 |
122 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98488369 |
123 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97212629 |
124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96801513 |
125 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.96400955 |
126 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96073282 |
127 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96071983 |
128 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94950307 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 3.71807333 |
2 | MP0005451_abnormal_body_composition | 3.29721431 |
3 | MP0003111_abnormal_nucleus_morphology | 3.15729918 |
4 | MP0003077_abnormal_cell_cycle | 2.73879217 |
5 | MP0010094_abnormal_chromosome_stability | 2.62603148 |
6 | MP0004957_abnormal_blastocyst_morpholog | 2.58169480 |
7 | MP0008260_abnormal_autophagy | 2.56904556 |
8 | MP0003705_abnormal_hypodermis_morpholog | 2.53526143 |
9 | MP0010352_gastrointestinal_tract_polyps | 2.52848488 |
10 | MP0003724_increased_susceptibility_to | 2.52194852 |
11 | MP0008057_abnormal_DNA_replication | 2.38705558 |
12 | MP0000465_gastrointestinal_hemorrhage | 2.36916147 |
13 | MP0003436_decreased_susceptibility_to | 2.34660980 |
14 | MP0009840_abnormal_foam_cell | 2.29246781 |
15 | MP0010307_abnormal_tumor_latency | 2.25637838 |
16 | MP0003303_peritoneal_inflammation | 2.22443554 |
17 | MP0000685_abnormal_immune_system | 2.06985695 |
18 | MP0001835_abnormal_antigen_presentation | 1.95188207 |
19 | MP0005076_abnormal_cell_differentiation | 1.94467042 |
20 | MP0002254_reproductive_system_inflammat | 1.87381463 |
21 | MP0009333_abnormal_splenocyte_physiolog | 1.84380390 |
22 | MP0006082_CNS_inflammation | 1.81752556 |
23 | MP0001800_abnormal_humoral_immune | 1.81671801 |
24 | MP0009278_abnormal_bone_marrow | 1.76710156 |
25 | MP0008007_abnormal_cellular_replicative | 1.76632586 |
26 | MP0000350_abnormal_cell_proliferation | 1.75549828 |
27 | MP0008058_abnormal_DNA_repair | 1.71707465 |
28 | MP0005397_hematopoietic_system_phenotyp | 1.69818040 |
29 | MP0001545_abnormal_hematopoietic_system | 1.69818040 |
30 | MP0002452_abnormal_antigen_presenting | 1.69201836 |
31 | MP0001730_embryonic_growth_arrest | 1.64906055 |
32 | MP0002398_abnormal_bone_marrow | 1.64810204 |
33 | MP0002138_abnormal_hepatobiliary_system | 1.59652903 |
34 | MP0009764_decreased_sensitivity_to | 1.54837762 |
35 | MP0002396_abnormal_hematopoietic_system | 1.53969704 |
36 | MP0003075_altered_response_to | 1.53635181 |
37 | MP0000490_abnormal_crypts_of | 1.53541312 |
38 | MP0004510_myositis | 1.52399770 |
39 | MP0000604_amyloidosis | 1.51602684 |
40 | MP0005000_abnormal_immune_tolerance | 1.50745642 |
41 | MP0002723_abnormal_immune_serum | 1.50674409 |
42 | MP0000689_abnormal_spleen_morphology | 1.50535165 |
43 | MP0003763_abnormal_thymus_physiology | 1.50334680 |
44 | MP0002722_abnormal_immune_system | 1.47403186 |
45 | MP0001819_abnormal_immune_cell | 1.45667311 |
46 | MP0002420_abnormal_adaptive_immunity | 1.45548724 |
47 | MP0000343_altered_response_to | 1.40394820 |
48 | MP0004947_skin_inflammation | 1.40374807 |
49 | MP0003566_abnormal_cell_adhesion | 1.39025766 |
50 | MP0000716_abnormal_immune_system | 1.38702788 |
51 | MP0003656_abnormal_erythrocyte_physiolo | 1.37123487 |
52 | MP0001790_abnormal_immune_system | 1.35612585 |
53 | MP0005387_immune_system_phenotype | 1.35612585 |
54 | MP0009785_altered_susceptibility_to | 1.35212234 |
55 | MP0002419_abnormal_innate_immunity | 1.33249834 |
56 | MP0002429_abnormal_blood_cell | 1.32879157 |
57 | MP0005025_abnormal_response_to | 1.32241220 |
58 | MP0005310_abnormal_salivary_gland | 1.31806158 |
59 | MP0002019_abnormal_tumor_incidence | 1.31271536 |
60 | MP0008932_abnormal_embryonic_tissue | 1.31001076 |
61 | MP0000703_abnormal_thymus_morphology | 1.30836145 |
62 | MP0005380_embryogenesis_phenotype | 1.29948786 |
63 | MP0001672_abnormal_embryogenesis/_devel | 1.29948786 |
64 | MP0004808_abnormal_hematopoietic_stem | 1.28206376 |
65 | MP0000313_abnormal_cell_death | 1.26590906 |
66 | MP0005464_abnormal_platelet_physiology | 1.26583215 |
67 | MP0003984_embryonic_growth_retardation | 1.22962956 |
68 | MP0002080_prenatal_lethality | 1.22730826 |
69 | MP0002405_respiratory_system_inflammati | 1.22008328 |
70 | MP0006292_abnormal_olfactory_placode | 1.21824177 |
71 | MP0002088_abnormal_embryonic_growth/wei | 1.21472260 |
72 | MP0005360_urolithiasis | 1.20526066 |
73 | MP0005058_abnormal_lysosome_morphology | 1.20281816 |
74 | MP0003646_muscle_fatigue | 1.18690422 |
75 | MP0002998_abnormal_bone_remodeling | 1.17748714 |
76 | MP0001697_abnormal_embryo_size | 1.16479416 |
77 | MP0002086_abnormal_extraembryonic_tissu | 1.16477622 |
78 | MP0010155_abnormal_intestine_physiology | 1.10896469 |
79 | MP0005023_abnormal_wound_healing | 1.10812555 |
80 | MP0003448_altered_tumor_morphology | 1.10130416 |
81 | MP0001851_eye_inflammation | 1.08429008 |
82 | MP0003806_abnormal_nucleotide_metabolis | 1.08214250 |
83 | MP0001845_abnormal_inflammatory_respons | 1.07262987 |
84 | MP0000858_altered_metastatic_potential | 1.06788646 |
85 | MP0001986_abnormal_taste_sensitivity | 1.05902354 |
86 | MP0003191_abnormal_cellular_cholesterol | 1.05849600 |
87 | MP0003172_abnormal_lysosome_physiology | 1.05021939 |
88 | MP0004185_abnormal_adipocyte_glucose | 1.04642385 |
89 | MP0003300_gastrointestinal_ulcer | 1.02318068 |
90 | MP0004197_abnormal_fetal_growth/weight/ | 1.01652808 |
91 | MP0005621_abnormal_cell_physiology | 1.00746713 |
92 | MP0005671_abnormal_response_to | 1.00558859 |
93 | MP0002933_joint_inflammation | 1.00135229 |
94 | MP0006036_abnormal_mitochondrial_physio | 0.98516067 |
95 | MP0003828_pulmonary_edema | 0.98288065 |
96 | MP0003453_abnormal_keratinocyte_physiol | 0.98116120 |
97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97311980 |
98 | MP0003123_paternal_imprinting | 0.97277335 |
99 | MP0002085_abnormal_embryonic_tissue | 0.96953642 |
100 | MP0000609_abnormal_liver_physiology | 0.96417576 |
101 | MP0002084_abnormal_developmental_patter | 0.94527011 |
102 | MP0002332_abnormal_exercise_endurance | 0.93198503 |
103 | MP0008004_abnormal_stomach_pH | 0.93142187 |
104 | MP0003329_amyloid_beta_deposits | 0.92346579 |
105 | MP0008469_abnormal_protein_level | 0.91537908 |
106 | MP0001853_heart_inflammation | 0.90958348 |
107 | MP0002139_abnormal_hepatobiliary_system | 0.90725588 |
108 | MP0000598_abnormal_liver_morphology | 0.88556519 |
109 | MP0001293_anophthalmia | 0.88135419 |
110 | MP0002166_altered_tumor_susceptibility | 0.88131135 |
111 | MP0003091_abnormal_cell_migration | 0.87396345 |
112 | MP0001663_abnormal_digestive_system | 0.85446021 |
113 | MP0005666_abnormal_adipose_tissue | 0.84654073 |
114 | MP0000358_abnormal_cell_content/ | 0.83495561 |
115 | MP0002148_abnormal_hypersensitivity_rea | 0.81961493 |
116 | MP0001873_stomach_inflammation | 0.81321782 |
117 | MP0001533_abnormal_skeleton_physiology | 0.81057214 |
118 | MP0005384_cellular_phenotype | 0.80771249 |
119 | MP0001727_abnormal_embryo_implantation | 0.80595995 |
120 | MP0003786_premature_aging | 0.79764516 |
121 | MP0004264_abnormal_extraembryonic_tissu | 0.79687582 |
122 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79000239 |
123 | MP0001915_intracranial_hemorrhage | 0.78912546 |
124 | MP0008995_early_reproductive_senescence | 0.77196754 |
125 | MP0002877_abnormal_melanocyte_morpholog | 0.76750526 |
126 | MP0009763_increased_sensitivity_to | 0.76657701 |
127 | MP0005647_abnormal_sex_gland | 0.75734005 |
128 | MP0008874_decreased_physiological_sensi | 0.73864034 |
129 | MP0002653_abnormal_ependyma_morphology | 0.73390079 |
130 | MP0004233_abnormal_muscle_weight | 0.73055693 |
131 | MP0003186_abnormal_redox_activity | 0.70531142 |
132 | MP0005166_decreased_susceptibility_to | 0.69874982 |
133 | MP0005319_abnormal_enzyme/_coenzyme | 0.69802212 |
134 | MP0006054_spinal_hemorrhage | 0.69273002 |
135 | MP0006035_abnormal_mitochondrial_morpho | 0.68376073 |
136 | MP0002132_abnormal_respiratory_system | 0.67913938 |
137 | MP0002234_abnormal_pharynx_morphology | 0.67899334 |
138 | MP0005390_skeleton_phenotype | 0.66151933 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Autoimmune hemolytic anemia (HP:0001890) | 4.54458233 |
2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.49785784 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.49785784 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.49785784 |
5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.42124503 |
6 | Recurrent abscess formation (HP:0002722) | 3.71886524 |
7 | Loss of speech (HP:0002371) | 3.68416289 |
8 | Recurrent bacterial skin infections (HP:0005406) | 3.66394193 |
9 | Granulocytopenia (HP:0001913) | 3.63918567 |
10 | Increased cerebral lipofuscin (HP:0011813) | 3.62056788 |
11 | Ragged-red muscle fibers (HP:0003200) | 3.48792118 |
12 | Hypochromic anemia (HP:0001931) | 3.47783363 |
13 | Eosinophilia (HP:0001880) | 3.47549701 |
14 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.46786300 |
15 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.46786300 |
16 | Ependymoma (HP:0002888) | 3.37128819 |
17 | Dysostosis multiplex (HP:0000943) | 3.25502967 |
18 | Eczematoid dermatitis (HP:0000976) | 3.21250360 |
19 | Pustule (HP:0200039) | 3.16749114 |
20 | Autoimmune thrombocytopenia (HP:0001973) | 3.10253456 |
21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.09327669 |
22 | Abnormality of T cell number (HP:0011839) | 2.99625146 |
23 | Urticaria (HP:0001025) | 2.86769681 |
24 | Abnormality of the columella (HP:0009929) | 2.80169150 |
25 | Multiple enchondromatosis (HP:0005701) | 2.75840666 |
26 | Petechiae (HP:0000967) | 2.72532044 |
27 | Agnosia (HP:0010524) | 2.71879639 |
28 | Progressive external ophthalmoplegia (HP:0000590) | 2.68985399 |
29 | Carpal bone hypoplasia (HP:0001498) | 2.68675276 |
30 | Optic neuritis (HP:0100653) | 2.67897880 |
31 | Retrobulbar optic neuritis (HP:0100654) | 2.67897880 |
32 | Stomatitis (HP:0010280) | 2.65637591 |
33 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64605201 |
34 | Hepatosplenomegaly (HP:0001433) | 2.64254759 |
35 | Vasculitis (HP:0002633) | 2.59308074 |
36 | Pseudobulbar signs (HP:0002200) | 2.57662937 |
37 | Myositis (HP:0100614) | 2.56609699 |
38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56404171 |
39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56404171 |
40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56404171 |
41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55122141 |
42 | Obstructive lung disease (HP:0006536) | 2.51572517 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51572517 |
44 | Abnormality of eosinophils (HP:0001879) | 2.50399667 |
45 | Poikiloderma (HP:0001029) | 2.49596977 |
46 | Conjunctival telangiectasia (HP:0000524) | 2.48493414 |
47 | Vacuolated lymphocytes (HP:0001922) | 2.47799314 |
48 | Myocardial infarction (HP:0001658) | 2.47180886 |
49 | Hematochezia (HP:0002573) | 2.40631269 |
50 | Breast hypoplasia (HP:0003187) | 2.39561280 |
51 | Thrombocytosis (HP:0001894) | 2.37244258 |
52 | Abnormality of macrophages (HP:0004311) | 2.37017373 |
53 | Neonatal hypoglycemia (HP:0001998) | 2.34332014 |
54 | Hypergammaglobulinemia (HP:0010702) | 2.34208489 |
55 | Systemic lupus erythematosus (HP:0002725) | 2.33892126 |
56 | Personality changes (HP:0000751) | 2.33553730 |
57 | Entropion (HP:0000621) | 2.33392018 |
58 | Recurrent fungal infections (HP:0002841) | 2.31943574 |
59 | Mucopolysacchariduria (HP:0008155) | 2.31464959 |
60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31464959 |
61 | Meningitis (HP:0001287) | 2.31273211 |
62 | Birth length less than 3rd percentile (HP:0003561) | 2.30866724 |
63 | Upper motor neuron abnormality (HP:0002127) | 2.25313106 |
64 | Gingivitis (HP:0000230) | 2.22608407 |
65 | Recurrent viral infections (HP:0004429) | 2.21922299 |
66 | Prominent nose (HP:0000448) | 2.20250821 |
67 | Abnormality of the astrocytes (HP:0100707) | 2.18075482 |
68 | Astrocytoma (HP:0009592) | 2.18075482 |
69 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.17783814 |
70 | Thoracic kyphosis (HP:0002942) | 2.15229530 |
71 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15040180 |
72 | Agammaglobulinemia (HP:0004432) | 2.14589063 |
73 | Ulnar bowing (HP:0003031) | 2.14393371 |
74 | Abnormal gallbladder physiology (HP:0012438) | 2.13969769 |
75 | Cholecystitis (HP:0001082) | 2.13969769 |
76 | Apathy (HP:0000741) | 2.13944654 |
77 | Facial hemangioma (HP:0000329) | 2.13687220 |
78 | Mediastinal lymphadenopathy (HP:0100721) | 2.12032273 |
79 | Patellar aplasia (HP:0006443) | 2.10536062 |
80 | Diminished motivation (HP:0000745) | 2.09424189 |
81 | Easy fatigability (HP:0003388) | 2.09410678 |
82 | Cellulitis (HP:0100658) | 2.08996439 |
83 | Recurrent skin infections (HP:0001581) | 2.08649702 |
84 | Selective tooth agenesis (HP:0001592) | 2.07045092 |
85 | Fatigue (HP:0012378) | 2.06908897 |
86 | Myelodysplasia (HP:0002863) | 2.06073833 |
87 | Abnormality of the fingertips (HP:0001211) | 2.05993722 |
88 | Global brain atrophy (HP:0002283) | 2.05433012 |
89 | Chromsome breakage (HP:0040012) | 2.05159438 |
90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04164003 |
91 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.03709738 |
92 | Increased serum ferritin (HP:0003281) | 2.03121290 |
93 | Increased IgM level (HP:0003496) | 2.02787259 |
94 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.00289554 |
95 | Nasal polyposis (HP:0100582) | 1.99691051 |
96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99641583 |
97 | Purpura (HP:0000979) | 1.99379229 |
98 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.98251084 |
99 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.97593841 |
100 | Premature skin wrinkling (HP:0100678) | 1.94274831 |
101 | Hypertensive crisis (HP:0100735) | 1.92594442 |
102 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.91466827 |
103 | Neutropenia (HP:0001875) | 1.91304664 |
104 | Premature ovarian failure (HP:0008209) | 1.91301905 |
105 | Colitis (HP:0002583) | 1.90587888 |
106 | Reticulocytopenia (HP:0001896) | 1.90362722 |
107 | Abnormality of the lower motor neuron (HP:0002366) | 1.90335187 |
108 | Bone marrow hypocellularity (HP:0005528) | 1.90182547 |
109 | Encephalitis (HP:0002383) | 1.89881124 |
110 | Osteomyelitis (HP:0002754) | 1.88412708 |
111 | Abnormality of the intervertebral disk (HP:0005108) | 1.87316016 |
112 | Neoplasm of striated muscle (HP:0009728) | 1.86440703 |
113 | Neuronal loss in central nervous system (HP:0002529) | 1.85787300 |
114 | Basal cell carcinoma (HP:0002671) | 1.85032941 |
115 | Abnormality of T cell physiology (HP:0011840) | 1.83769102 |
116 | Disinhibition (HP:0000734) | 1.83327808 |
117 | Hypergonadotropic hypogonadism (HP:0000815) | 1.82152921 |
118 | Microretrognathia (HP:0000308) | 1.81963091 |
119 | Abnormality of reticulocytes (HP:0004312) | 1.81890094 |
120 | Keratoconjunctivitis sicca (HP:0001097) | 1.81842816 |
121 | Abnormality of the thoracic spine (HP:0100711) | 1.81802912 |
122 | Impulsivity (HP:0100710) | 1.81400291 |
123 | Mutism (HP:0002300) | 1.80747807 |
124 | Progressive muscle weakness (HP:0003323) | 1.78391673 |
125 | Hand muscle atrophy (HP:0009130) | 1.77204437 |
126 | Reticulocytosis (HP:0001923) | 1.77124240 |
127 | Cafe-au-lait spot (HP:0000957) | 1.75498610 |
128 | Proximal placement of thumb (HP:0009623) | 1.75215943 |
129 | Medulloblastoma (HP:0002885) | 1.74846443 |
130 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.74668624 |
131 | Gastrointestinal infarctions (HP:0005244) | 1.74445870 |
132 | Abnormality of homocysteine metabolism (HP:0010919) | 1.73980490 |
133 | Homocystinuria (HP:0002156) | 1.73980490 |
134 | Orchitis (HP:0100796) | 1.72748191 |
135 | Rough bone trabeculation (HP:0100670) | 1.72691315 |
136 | Enlarged epiphyses (HP:0010580) | 1.72666764 |
137 | Leukocytosis (HP:0001974) | 1.72585382 |
138 | Emphysema (HP:0002097) | 1.72408311 |
139 | Abnormality of iron homeostasis (HP:0011031) | 1.72238807 |
140 | Rhabdomyosarcoma (HP:0002859) | 1.72218095 |
141 | Keratoconjunctivitis (HP:0001096) | 1.71557204 |
142 | Abnormality of T cells (HP:0002843) | 1.71413002 |
143 | Polyneuropathy (HP:0001271) | 1.71019583 |
144 | Impaired platelet aggregation (HP:0003540) | 1.70678224 |
145 | Abnormal platelet function (HP:0011869) | 1.70678224 |
146 | Deviation of the thumb (HP:0009603) | 1.70073287 |
147 | Nausea (HP:0002018) | 1.70003548 |
148 | Impaired proprioception (HP:0010831) | 1.69517714 |
149 | Lymphoma (HP:0002665) | 1.67971709 |
150 | Vertebral fusion (HP:0002948) | 1.67706739 |
151 | Nuclear cataract (HP:0100018) | 1.67621407 |
152 | Sparse lateral eyebrow (HP:0005338) | 1.67096691 |
153 | Increased muscle lipid content (HP:0009058) | 1.66916050 |
154 | Microvesicular hepatic steatosis (HP:0001414) | 1.66817600 |
155 | Abnormality of DNA repair (HP:0003254) | 1.66750547 |
156 | Anomalous pulmonary venous return (HP:0010772) | 1.66010623 |
157 | Poor head control (HP:0002421) | 1.65440509 |
158 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.64760219 |
159 | Abnormal neuron morphology (HP:0012757) | 1.64661882 |
160 | Abnormality of the motor neurons (HP:0002450) | 1.64661882 |
161 | Pallor (HP:0000980) | 1.64616964 |
162 | Polycythemia (HP:0001901) | 1.64529560 |
163 | Abnormality of the nasal mucosa (HP:0000433) | 1.63666127 |
164 | Anorexia (HP:0002039) | 1.62882988 |
165 | Overlapping toe (HP:0001845) | 1.62771941 |
166 | Abnormality of chromosome stability (HP:0003220) | 1.62719642 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 4.85350171 |
2 | INSRR | 3.19501955 |
3 | PRPF4B | 3.05231150 |
4 | NEK2 | 2.68654643 |
5 | TAOK2 | 2.39668009 |
6 | TRIB3 | 2.35844325 |
7 | BUB1 | 2.28865714 |
8 | MAP3K10 | 2.11610970 |
9 | MAP4K1 | 2.08680533 |
10 | EEF2K | 2.02952451 |
11 | DYRK3 | 2.02419459 |
12 | TESK2 | 1.96683342 |
13 | CDK19 | 1.90667151 |
14 | CDC7 | 1.89503740 |
15 | PIK3CA | 1.86670690 |
16 | PKN2 | 1.83387478 |
17 | STK10 | 1.80310366 |
18 | ERN1 | 1.72481624 |
19 | WEE1 | 1.71571879 |
20 | GRK7 | 1.68929515 |
21 | NME2 | 1.67467275 |
22 | SRPK1 | 1.65333735 |
23 | TBK1 | 1.63593603 |
24 | PIM1 | 1.57547738 |
25 | TYK2 | 1.56248180 |
26 | RPS6KA4 | 1.53905766 |
27 | FES | 1.52757708 |
28 | MAP2K3 | 1.52122417 |
29 | MATK | 1.50437784 |
30 | TAOK1 | 1.49452518 |
31 | EIF2AK1 | 1.44208572 |
32 | BMPR2 | 1.42537944 |
33 | IRAK3 | 1.41383248 |
34 | BRD4 | 1.39644123 |
35 | MOS | 1.38103449 |
36 | PLK4 | 1.33978827 |
37 | CDK4 | 1.33191340 |
38 | TGFBR2 | 1.31898049 |
39 | SCYL2 | 1.27852966 |
40 | TTK | 1.25873025 |
41 | ZAP70 | 1.25094959 |
42 | FGR | 1.22252555 |
43 | SIK3 | 1.20716586 |
44 | CDK7 | 1.20287089 |
45 | CAMK1D | 1.17829772 |
46 | MAP3K6 | 1.14808418 |
47 | TSSK6 | 1.13571919 |
48 | DYRK1B | 1.11244303 |
49 | IRAK2 | 1.06991033 |
50 | MAP2K2 | 1.06459477 |
51 | CAMKK2 | 1.06178463 |
52 | STK4 | 1.04558397 |
53 | GRK6 | 1.03880962 |
54 | AURKB | 1.03318349 |
55 | TLK1 | 1.02721538 |
56 | LATS2 | 1.02456361 |
57 | MAP3K8 | 1.02408079 |
58 | MARK3 | 1.02237848 |
59 | RPS6KB2 | 1.00989229 |
60 | MAPK12 | 1.00755606 |
61 | MAP3K11 | 1.00715951 |
62 | PAK4 | 1.00685480 |
63 | ALK | 1.00372194 |
64 | TXK | 1.00268401 |
65 | CHEK2 | 0.99945335 |
66 | PLK1 | 0.99226934 |
67 | IKBKB | 0.98053507 |
68 | RIPK4 | 0.96691186 |
69 | MELK | 0.95918068 |
70 | JAK3 | 0.94973155 |
71 | SMG1 | 0.94664863 |
72 | PIM2 | 0.90525389 |
73 | STK3 | 0.88789250 |
74 | CSK | 0.88611387 |
75 | ACVR1B | 0.87922378 |
76 | TESK1 | 0.87411748 |
77 | MAP2K6 | 0.85980436 |
78 | PRKD2 | 0.85638612 |
79 | MAP3K14 | 0.83710884 |
80 | MAP3K3 | 0.83492392 |
81 | CSF1R | 0.83377410 |
82 | IKBKE | 0.81986558 |
83 | MAPKAPK3 | 0.80183574 |
84 | LCK | 0.79716837 |
85 | MAP3K1 | 0.79335796 |
86 | RIPK1 | 0.77493565 |
87 | PBK | 0.76758016 |
88 | ATR | 0.76185105 |
89 | CDK6 | 0.76144952 |
90 | PDK2 | 0.73563919 |
91 | FLT3 | 0.73562347 |
92 | CLK1 | 0.73561822 |
93 | BLK | 0.73042959 |
94 | SIK1 | 0.73031329 |
95 | BRSK2 | 0.72787258 |
96 | EIF2AK3 | 0.72025821 |
97 | MTOR | 0.71315391 |
98 | EPHA2 | 0.70994914 |
99 | IRAK4 | 0.70953202 |
100 | RET | 0.70416109 |
101 | CHEK1 | 0.69060915 |
102 | BMX | 0.68891775 |
103 | LRRK2 | 0.67084665 |
104 | SYK | 0.65904229 |
105 | LYN | 0.65311559 |
106 | CHUK | 0.64808656 |
107 | MAP2K4 | 0.62866708 |
108 | NLK | 0.59583646 |
109 | KIT | 0.59345968 |
110 | BTK | 0.58235497 |
111 | ABL2 | 0.58065562 |
112 | PAK1 | 0.57512002 |
113 | JAK1 | 0.57126637 |
114 | ICK | 0.57096868 |
115 | MAP3K5 | 0.56088895 |
116 | AURKA | 0.55704471 |
117 | PTK6 | 0.55479775 |
118 | CDK2 | 0.55244370 |
119 | JAK2 | 0.55220279 |
120 | LATS1 | 0.54535007 |
121 | MARK2 | 0.52847065 |
122 | ARAF | 0.52711140 |
123 | TAOK3 | 0.52516549 |
124 | HCK | 0.51968007 |
125 | KSR2 | 0.51576299 |
126 | KDR | 0.50709067 |
127 | BRAF | 0.49109898 |
128 | RAF1 | 0.48902773 |
129 | TTN | 0.48411533 |
130 | MAPKAPK2 | 0.47801218 |
131 | CDK9 | 0.47784846 |
132 | MAPK11 | 0.47533448 |
133 | TNK2 | 0.45781599 |
134 | NEK1 | 0.44304432 |
135 | BCKDK | 0.43601837 |
136 | ATM | 0.41982499 |
137 | MUSK | 0.40626545 |
138 | EPHB1 | 0.39947402 |
139 | SIK2 | 0.35066131 |
140 | PRKD1 | 0.30385584 |
141 | VRK2 | 0.29984668 |
142 | AKT2 | 0.29743321 |
143 | MAPK7 | 0.27880733 |
144 | CDC42BPA | 0.27650212 |
145 | RPS6KC1 | 0.26429777 |
146 | RPS6KL1 | 0.26429777 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 2.83565853 |
2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.73980270 |
3 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.37638282 |
4 | Sulfur relay system_Homo sapiens_hsa04122 | 2.37108717 |
5 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.29644426 |
6 | RNA polymerase_Homo sapiens_hsa03020 | 2.28455785 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 2.24105511 |
8 | RNA transport_Homo sapiens_hsa03013 | 2.21162634 |
9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17658672 |
10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.10208857 |
11 | Cell cycle_Homo sapiens_hsa04110 | 1.94505933 |
12 | Spliceosome_Homo sapiens_hsa03040 | 1.92081058 |
13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.87671065 |
14 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.83094397 |
15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.80444774 |
16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79378405 |
17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75087623 |
18 | Base excision repair_Homo sapiens_hsa03410 | 1.74294769 |
19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.68255178 |
20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67874554 |
21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60236169 |
22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.55114426 |
23 | Homologous recombination_Homo sapiens_hsa03440 | 1.53084775 |
24 | Ribosome_Homo sapiens_hsa03010 | 1.52038606 |
25 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.47584534 |
26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45046721 |
27 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.44694629 |
28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44590635 |
29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42129856 |
30 | Proteasome_Homo sapiens_hsa03050 | 1.41750557 |
31 | Apoptosis_Homo sapiens_hsa04210 | 1.39713778 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39492364 |
33 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.33790355 |
34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31140787 |
35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28954835 |
36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28502392 |
37 | Salmonella infection_Homo sapiens_hsa05132 | 1.27103656 |
38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26806370 |
39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.26802071 |
40 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.23235084 |
41 | Legionellosis_Homo sapiens_hsa05134 | 1.19063676 |
42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.17604141 |
43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16090363 |
44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.14655135 |
45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12623663 |
46 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.12398435 |
47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12002724 |
48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05647864 |
49 | RNA degradation_Homo sapiens_hsa03018 | 1.05033602 |
50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05021037 |
51 | Measles_Homo sapiens_hsa05162 | 1.03995501 |
52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03468303 |
53 | Shigellosis_Homo sapiens_hsa05131 | 1.02802963 |
54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01475045 |
55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01388589 |
56 | Basal transcription factors_Homo sapiens_hsa03022 | 1.01107558 |
57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00236394 |
58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98140893 |
59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96549042 |
60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95024294 |
61 | Hepatitis B_Homo sapiens_hsa05161 | 0.94740484 |
62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94277621 |
63 | Influenza A_Homo sapiens_hsa05164 | 0.94246444 |
64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91132722 |
65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90869635 |
66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89403523 |
67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88296917 |
68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86730575 |
69 | Tuberculosis_Homo sapiens_hsa05152 | 0.86357000 |
70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85727534 |
71 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83906903 |
72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83832331 |
73 | Hepatitis C_Homo sapiens_hsa05160 | 0.82565099 |
74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80806177 |
75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79411502 |
76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77140888 |
77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75982164 |
78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74705129 |
79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.72598041 |
80 | Phagosome_Homo sapiens_hsa04145 | 0.71771569 |
81 | Malaria_Homo sapiens_hsa05144 | 0.70692964 |
82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68860190 |
83 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68669141 |
84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68361570 |
85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68070033 |
86 | Pertussis_Homo sapiens_hsa05133 | 0.65313034 |
87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65268185 |
88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64404415 |
89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63035112 |
90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62839652 |
91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62614642 |
92 | Allograft rejection_Homo sapiens_hsa05330 | 0.61815824 |
93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60999959 |
94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59560282 |
95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59496627 |
96 | Bladder cancer_Homo sapiens_hsa05219 | 0.58691817 |
97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58125772 |
98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57892436 |
99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57469753 |
100 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56755203 |
101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56382498 |
102 | Lysine degradation_Homo sapiens_hsa00310 | 0.55077951 |
103 | Asthma_Homo sapiens_hsa05310 | 0.54050354 |
104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52034025 |
105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51783343 |
106 | Prion diseases_Homo sapiens_hsa05020 | 0.51637520 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51320952 |
108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50669810 |
109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50144379 |
110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50002010 |
111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49803124 |
112 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.49746550 |
113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49286826 |
114 | Purine metabolism_Homo sapiens_hsa00230 | 0.49192480 |
115 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49069010 |
116 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48545877 |
117 | Lysosome_Homo sapiens_hsa04142 | 0.48143388 |
118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47594399 |
119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46900198 |
120 | Insulin resistance_Homo sapiens_hsa04931 | 0.46825958 |
121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46476517 |
122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45600925 |
123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44993114 |
124 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44280939 |
125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44022186 |
126 | Prostate cancer_Homo sapiens_hsa05215 | 0.43866841 |
127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41795118 |
128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38598371 |
129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35916711 |
130 | Endocytosis_Homo sapiens_hsa04144 | 0.31787547 |